Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_assertion type Assertion NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_head.
- NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_provenance.
- NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_assertion evidence source_evidence_literature NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_provenance.
- NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_assertion SIO_000772 11485622 NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_provenance.
- NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_assertion wasDerivedFrom befree-2016 NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_provenance.
- NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_assertion wasGeneratedBy ECO_0000203 NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_provenance.